Displaying 1 to 20 of 35 investments
Country Notes
Amura Ltd
A structure-based drug discovery business specialising in diseases such as osteoporosis, osteoarthritis, bone metasta. Secondary sale in February 2005
United Kingdom N/A
Ardana PLC
Drugs for reproductive disorders and hormone sensitive cancers. IPO in March 2005.
United Kingdom N/A
Ark Therapeutics Group PLC
Gene-based drugs for vascular and circulatory diseases and cancer. IPO in March 2004.
United Kingdom N/A
Biovertis AG
Hospital-acquired infections; respiratory tract infections; urinary tract infections. Acquired Morphochem AG in March 2006.
Austria N/A
Biovex Inc
Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease.
United States N/A
Active
Biowisdom Ltd
Knowledge management software for drug development.
United Kingdom N/A
Cambridge Biotechnology Ltd
Small molecule drugs for pain and obesity. Aquired by Biovitrum AB in April 2005.
United Kingdom N/A
Cyclacel Pharmaceutical Inc
Cell cycle control drugs for cancer. IPO in January 2006.
United States N/A
De Novo Pharmaceuticals Ltd
A world leader in in-silico structure-based drug design, de novo drug design.
United Kingdom N/A
Decon Sciences Ltd
Decontamination services provider
United Kingdom N/A
DestinationSkin Ltd
Skin treatment and hair removal.
United Kingdom N/A
Emergent BioSolutions Inc
Research, development and manufacture of novel vaccines and related products IPO in November 2006. Fully disposed.
United States N/A
Energist Ltd
Manufactures and markets lasers and light-based systems for hair removal and aesthetic skin treatments, serving both the medical and beauty sectors.
United Kingdom N/A
EpiCept Inc
Topical pain management. IPO in January 2006.
United States N/A
Intercytex Group PLC
A UK Regenerative Medicine Company product and services. IPO in February 2006. Presently known as Regenerative Medicine Assets Ltd.
United Kingdom N/A
KinderTec Ltd
Paediatric consumer healthcare products. Trade sale in December 2005.
United Kingdom N/A
Lab21 Ltd
United Kingdom N/A
LiDCO Group PLC
Researches, develops, manufactures and sells innovative medical devices. IPO in June 2004.
United Kingdom N/A
Microscience Investments Ltd
Vaccines for typhoid, travellers’ illnesses and hepatitis B Merged with NASDAQ listed Emergent Biosolutions Inc in July 2005.
United Kingdom N/A
Neurotech Pharmaceuticals Inc
Cell-based drugs for diseases of the eye.
United States N/A